Biocon Ltd share price logo

Biocon Share Price

NSE: BIOCON

BSE: 532523

Mid Cap

Healthcare Sector

₹417.00

+11.10

(+2.73%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Biocon Stock Performance

as on November 13, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹405.75
    ₹423.1
    downward going graph

    2.70%

    Downside

    1.46%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹291
    ₹425.2
    downward going graph

    30.22%

    Downside

    1.97%

    Upside

    downward going graph

Biocon share price movements today

Previous Close
₹405.90
Open
₹407.15
Volume
1.25Cr
Upper Circuit
₹446.45
Lower Circuit
₹365.35
Day's Low - High
₹405.75 - ₹423.1
52 Week Low - High
₹291 - ₹425.2

Biocon Historical Returns

1 Month Return
+ 18.52 %
3 Month Return
+ 16.08 %
1 Year Return
+ 24.18 %
3 Year Return
+ 45.8 %
5 Year Return
-3.99 %

Biocon Fundamentals

as on November 13, 2025 at 4:01 pm IST

Market Cap

₹55,751.38 Cr

Return on Equity (ROE)

0.4

PE Ratio (TTM)

103.99

Return on capital employed (ROCE)

2.07

Industry PE ratio

42.19

Beta (LTM)

1.17

P/B Ratio

3.55

Dividend Yield

0.15

PEG Ratio

-12.97

Quarterly Earnings Growth YOY

390.04

EPS (TTM)

11.91

Sector

Pharmaceuticals

Book Value

180.27

Technical Analysis

Bullish

View Technical Analysis

Biocon Stock Valuation

as on November 13, 2025 at 4:01 pm IST

Biocon in the last 5 years

  • Overview

  • Trends

Lowest (24.48x)

March 19, 2024

Industry (42.19x)

November 13, 2025

Today (103.99x)

November 13, 2025

Highest (123.84x)

July 18, 2025

LowHigh

Today’s Price to Earnings Ratio: 103.99x

Biocon Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biocon with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Biocon Ltd image
Biocon Ltd
BUY55,751.38-0.8%0.781,42915,261
Divis Laboratories Ltd image
Divis Laboratories Ltd
HOLD1,75,036.7118.28%0.502,1919,360
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,29,486.7936.1%0.661,91111,516
Gland Pharma Ltd image
Gland Pharma Ltd
HOLD30,137.240.11%0.536985,616
Cipla Ltd image
Cipla Ltd
BUY1,23,249.7320.92%0.515,29127,547
See all

Analyst Recommendation on Biocon Stock

Based on 20 analysts

BUY

55.00%

Buy

15.00%

Hold

30.00%

Sell

Based on 20 analysts, 55% of analysts recommend a 'BUY' rating for Biocon. Average target price of ₹378.45

Source: S&P Global Market Intelligence

Biocon Share Price Target

Get share price movements and forecasts by analysts on Biocon.

What analysts predicted

-9.24%DOWNSIDE

Target Price

₹378.45

Current Price

₹417

Analyzed by

20 Analysts

High

₹465

Target

₹378.45

Low

₹270

Biocon target price ₹378.45, a slight downside of -9.24% compared to current price of ₹417. According to 20 analysts rating.

Source: S&P Global Market Intelligence

Biocon Stock’s Investor Sentiment and Interest

Investment in Biocon Ltd Shares on INDmoney has grown by 7.42% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:7.42% versus previous 30 day period

Search interest for Biocon Ltd Stock has increased by 79% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:79% versus previous 30 day period

Biocon Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
2,941.1
3,773.9
3,422.6
3,392.6
3,548.7
3,863.8
3,376.1
3,545
3,773
4,358.1
3,910.1
4,262.5
Other Income
78.6
154.9
93.5
157.9
586.7
48.6
1,166.5
58.5
52.9
57.3
79.7
93
Total Income
3,019.7
3,928.8
3,516.1
3,620.2
4,540.4
3,965.7
4,599.4
3,648.9
3,874.3
4,474.3
4,021.6
4,388.5
Expenses
2,623.8
2,819.7
2,741.4
2,768.9
3,051
3,012.7
2,812.5
2,905
3,069.6
3,338.8
3,193
3,472
Operating Profit
317.3
954.2
681.2
623.7
497.7
851.1
563.6
640
703.4
1,019.3
717.1
790.5
Operating Profit Margin %
10.79%
25.28%
19.9%
18.38%
14.02%
22.03%
16.69%
18.05%
18.64%
23.39%
18.34%
18.55%
Profit Before Interest, Tax and Depreciation
395.9
1,109.1
774.7
851.3
1,489.4
953
1,786.9
743.9
804.7
1,135.5
828.6
916.5
Interest
120.3
248.8
233
247.7
266.7
227
236
225.6
223.4
212.4
276.7
272.2
Depreciation
301.1
363.7
358
389.3
414.5
407
405.4
419.9
425.4
436.3
455
473
Profit Before Tax
-25.5
496.6
183.7
214.3
808.2
319
1,145.5
98.4
155.9
486.8
96.9
171.3
Tax Paid
-4.8
82.1
34.8
41.6
54.9
96.1
283.7
71.3
74.8
27.4
7.7
38.5
Profit After Tax
-20.7
414.5
148.9
172.7
753.3
222.9
861.8
27.1
81.1
459.4
89.2
132.8
Total Net profit including share of profit / Loss from associate company
-20.7
414.5
148.9
172.7
753.3
222.9
861.8
27.1
81.1
459.4
89.2
132.8
EPS
-0.35
2.62
0.85
1.05
5.52
1.13
5.51
-0.13
0.21
2.88
0.26
0.66
Actual EPS
-0.35
2.62
0.85
1.05
5.52
1.13
5.51
-0.13
0.21
2.88
0.26
0.66
Adjusted EPS
-0.35
2.62
0.85
1.05
5.52
1.13
5.51
-0.13
0.21
2.88
0.26
0.66
Diluted EPS
-0.35
2.62
0.85
1.05
5.51
1.13
5.51
-0.13
0.21
2.87
0.26
0.65

Biocon Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
3,891.1
4,123.4
5,514.4
6,300.5
7,143.1
8,184
11,174.2
14,195.8
15,052.2
Other Income
173.4
227.5
339.9
228.9
267.1
212.7
375.9
865.5
1,304.7
Total Income
4,064.5
4,350.9
5,854.3
6,529.4
7,410.2
8,396.7
11,550.1
15,621.2
16,566.4
Expenses
2,911.6
3,294.3
4,120.7
4,726.3
5,569.7
6,531.8
9,120.9
11,552.8
12,095.4
Operating Profit
979.5
829.1
1,393.7
1,574.2
1,573.4
1,652.2
2,053.3
2,643
2,956.8
Operating Profit Margin %
25.17%
20.11%
25.27%
24.99%
22.03%
20.19%
18.38%
18.62%
19.64%
Profit Before Interest, Tax and Depreciation
1,152.9
1,056.6
1,733.6
1,803.1
1,840.5
1,864.9
2,429.2
4,068.4
4,471
Interest
26
61.5
70.9
64.9
57.7
67.6
419
974.4
897.4
Depreciation
277.2
385.1
447.8
552.2
715.1
814.2
1,113.1
1,568.8
1,687
Profit Before Tax
849.7
610
1,214.9
1,186
1,067.7
983.1
897.1
1,525.2
1,886.6
Tax Paid
161.6
156.9
212.3
315.1
221.5
211.5
254.1
227.4
457.2
Profit After Tax
688.1
453.1
1,002.6
870.9
846.2
771.6
643
1,297.8
1,429.4
Total Net profit including share of profit / Loss from associate company
688.1
453.1
1,002.6
870.9
846.2
771.6
643
1,297.8
1,429.4
EPS
31.18
6.31
15.3
6.32
6.24
5.44
3.88
8.55
8.46
Actual EPS
31.18
6.31
15.3
6.32
6.24
5.44
3.88
8.55
8.46
Adjusted EPS
5.2
3.16
7.65
6.32
6.24
5.44
3.88
8.55
8.46
Diluted EPS
30.97
6.27
15.2
6.3
6.19
5.42
3.87
8.54
8.46

Biocon Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
370.6
640
662.1
1,154.6
1,283.1
1,159.7
1,176.6
1,852.5
2,953.9
4,061.2
Cash Flow from Investing Activities
-1,138.2
-509.8
-683.6
-702.6
-1,505.3
-3,651.4
-1,662
-14,260.1
-1,001.6
-202.9
Cash Flow from Financing Activities
1,067.6
-177.5
-239.7
-241.7
387.6
2,564
242.1
13,048.7
-2,332.7
-1,854
Net Cash Flow
300
-47.3
-261.2
210.3
165.4
72.3
-243.3
641.1
-380.4
2,004.3

Biocon Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
60.64%
60.64%
60.64%
60.64%
60.64%
60.64%
60.64%
60.64%
60.64%
60.64%
54.45%
54.45%
DII
8.63%
11.9%
12.56%
14.08%
14.51%
13.68%
14.3%
14.44%
15.37%
15.72%
22.82%
22.1%
FII
0%
0%
0%
7.96%
6.55%
5.63%
5.9%
5.93%
5.66%
5.66%
6.04%
6.61%
Public
15.73%
16.71%
16.76%
16.92%
17.96%
19.73%
18.89%
18.75%
18.12%
17.76%
16.5%
16.69%
Total Outstanding Shares
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,33,69,63,635
1,33,69,63,635
Total Shareholders
3,91,382
4,11,086
4,12,441
4,15,046
4,34,339
4,70,261
4,43,513
4,39,503
4,27,705
4,24,297
4,28,131
4,13,191

Mutual Funds that own Biocon Stock

Check out the Mutual Funds with significant holdings in Biocon.

Biocon Corporate Actions

View detailed summary of the earnings and dividend history of Biocon.

  • Biocon Ltd Earnings Results

    Biocon Ltd’s net profit jumped 628.13% since last year same period to ₹84.50Cr in the Q2 2025-2026. On a quarterly growth basis, Biocon Ltd has generated 169.11% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Biocon Ltd Dividends May,2025

    In the quarter ending March 2025, Biocon Ltd has declared dividend of ₹0.50 per share on 08 May 2025 - translating a dividend yield of 0.25%.

    Read More about Dividends

Indices Featuring Biocon Stock

Check stock indices that include Biocon.

Nifty Healthcare

₹14,809.35

0.18 (▲26.35%)

S&P BSE 400 MidSmallCap

₹12,290.28

-0.37 (▲-45.48%)

BSE Healthcare

₹44,554.46

-0.02 (▲-10.18%)

Nifty Midcap 150

₹22,322.45

-0.32 (▲-72%)

BSE Mid-Cap

₹47,199.03

-0.34 (▲-161.16%)

Nifty LargeMidcap 250

₹16,814.30

-0.15 (▲-25.45%)

Nifty Midcap 100

₹60,692.05

-0.35 (▲-210.25%)

Nifty 200

₹14,460.55

-0.05 (▲-6.6%)

BSE 200

₹11,739.05

-0.04 (▲-5.07%)

BSE 500

₹37,354.83

-0.08 (▲-30.8%)

S&P BSE 150 MidCap

₹16,526.61

-0.37 (▲-60.64%)

NIFTY PHARMA

₹22,686.80

0.41 (▲93.4%)

Nifty MidSmallcap 400

₹20,396.85

-0.35 (▲-71.6%)

Nifty 500

₹23,816.00

-0.09 (▲-20.9%)

S&P BSE 250 LargeMidCap

₹11,135.28

-0.05 (▲-5.88%)

Insights on Biocon Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 16.50% to 16.69% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BIOCON stock has moved up by 16.2%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 4.02K Cr → 4.38K Cr (in ₹), with an average increase of 8.4% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 6.04% to 6.61% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 31.4 Cr → 84.5 Cr (in ₹), with an average increase of 62.8% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.45% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 162.8% return, outperforming this stock by 120.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 69.6% return, outperforming this stock by 47.1%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 15.24% to 14.13% in Sep 2025 quarter

Biocon Stock Futures & Options Contracts

View the latest movement in Biocon Futures & Options, including strike prices, expiry dates, and percentage changes.

Biocon Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
BIOCON 25 Nov ₹420 Call
November 25, 2025
₹420
₹7.5
2.65
54.64%
BIOCON 25 Nov ₹430 Call
November 25, 2025
₹430
₹4.15
1.15
38.33%
BIOCON 25 Nov ₹415 Call
November 25, 2025
₹415
₹9.85
3.25
49.24%
BIOCON 25 Nov ₹410 Call
November 25, 2025
₹410
₹13
4.4
51.16%

Biocon Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
BIOCON 25 Nov Fut
November 25, 2025
-
₹417.9
10.15
2.49%
BIOCON 30 Dec Fut
December 30, 2025
-
₹420.65
10.22
2.49%
BIOCON 27 Jan Fut
January 27, 2026
-
₹423.45
10.81
2.62%

About Biocon Ltd

Biocon Ltd is a biopharmaceutical company founded in 1978 by Kiran Mazumdar-Shaw. It is headquartered in Bangalore, India and is one of the top biopharma companies in the world. The company operates in four core areas - biopharmaceuticals, biologics, research services, and clinical research. Biocon's biopharmaceuticals business focuses on biologics and biosimilars, while its biologics business focuses on the discovery, development and commercialization of novel biologics. Its research services include contract research and manufacturing services, while its clinical research business focuses on clinical trials and clinical data management.

Biocon's top products include insulin, monoclonal antibodies, enzymes, and vaccines. Its popular brands include Insugen, Insupen, and Insugen Plus. The company has a strong presence in the Indian market and is expanding its reach to other countries. Biocon has also established its presence in the US, Europe, and Japan.

Revenue: ₹4,262.50Cr as on September 2025 (Q2 FY26)
Net Profit: ₹132.80Cr as on September 2025 (Q2 FY26)
Listing date: 07 Apr, 2004
Chairperson Name: Kiran Mazumdar Shaw
OrganisationBiocon Ltd
HeadquartersBangalore
IndustryPharmaceuticals
CEOKiran Mazumdar Shaw
E-voting on sharesClick here to vote

FAQs

What is Biocon share price today?

Biocon share price today stands at ₹417 as on at the close of the market. Biocon share today touched a day high of ₹423.1 and a low of ₹405.75.

What is the 52 week high and 52 week low range for Biocon share?

Biocon touched a 52 week high of ₹425.2 and a 52 week low of ₹291. Biocon share price today i.e. is closed at ₹417, which is -1.93% down from its 52 week high and 43.30% up from its 52 week low.

What is Biocon's market capitalisation today?

Biocon market capitalisation is ₹55,751.38 Cr as on .

How to buy Biocon shares?

To buy Biocon shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BIOCON or Biocon Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Biocon shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Biocon trading volume today?

Biocon trading volume is 1.25Cr as on . This means that 1.25Cr shares of Biocon were bought and sold on the stock market during today's trading session.